Focused Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Focused Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30	Closed	-$201	–	482
2023 Q4	$201	Hold	30	–	–	﹤0.01%	958
2023 Q3	$169	Hold	30	–	–	﹤0.01%	970
2023 Q2	$166	Hold	30	–	–	﹤0.01%	1006
2023 Q1	$188	Hold	30	–	–	﹤0.01%	984
2022 Q4	$140	Sell	30 -11,055	-100%	-$54.5K	﹤0.01%	1035
2022 Q3	$52K	Sell	11,085 -620	-5%	-$3.91K	0.01%	271
2022 Q2	$69K	Sell	11,705 -3,794	-24%	-$42.2K	0.01%	243
2022 Q1	$300K	Sell	15,499 -210	-1%	-$4.82K	0.05%	119
2021 Q4	$513K	Sell	15,709 -2,701	-15%	-$109K	0.08%	94
2021 Q3	$755K	Sell	18,410 -825	-4%	-$29.9K	0.12%	70
2021 Q2	$693K	Buy	19,235 +150	+0.8%	+$5.54K	0.11%	79
2021 Q1	$745K	Buy	19,085 +14,409	+308%	+$648K	0.13%	80
2020 Q4	$189K	Buy	+4,676	New	+$215K	0.04%	159

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Focused Wealth Management's GDRX Position: Q1 2024 in Review

Focused Wealth Management sold out of GoodRx Holdings (GDRX) in Q1 2024, closing a stake of 30 shares — an estimated $201 sold.

Focused Wealth Management first reported a position in GDRX in Q4 2020 and held it in 13 quarters. The position peaked at $755K in Q3 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

Focused Wealth Management reported no remaining GoodRx Holdings position as of Q1 2024 after selling out during the quarter.
Focused Wealth Management sold 30 GoodRx Holdings shares in Q1 2024, an estimated $201.
Focused Wealth Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 13 quarters.
Focused Wealth Management's GoodRx Holdings position peaked at $755K in Q3 2021.
159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.